[ Price : $8.95]
FDA requires an additional postmarketing confirmatory study for full approval of Amgens Lumakras non-small cell lung cancer treatm...[ Price : $8.95]
FDA Webview closes its newsroom for the end-of-year Holiday Season, reopening Tuesday, January 2, 2024.[ Price : $8.95]
FDA approves a Merck NDA for Welireg (belzutifan) for treating patients with advanced kidney cancer following a programmed death r...[ Price : $8.95]
FDA approves a Glaukos Corp. NDA for iDOSE TR (travoprost intracameral implant) 75 mcg, a prostaglandin analog indicated for reduc...[ Price : $8.95]
Federal Register notice: FDA withdraws approval of the indications for mantle cell lymphoma and marginal zone lymphoma for Pharmac...[ Price : $8.95]
Federal Register notice: FDA sends to OMB an information collection proposal entitled A Survey on Quantitative Claims in Direct-to...[ Price : $8.95]
FDA updates its Risks and Complications of Breast Implants Web page that clarifies information about implant removal and adds ultr...[ Price : $8.95]
FDA posts a draft guidance entitled Priority Zoonotic Animal Drug (PZAD) Designation and Review Process.